1-7 of 7
Susanne Hagist
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Chemoimmunotherapy with Chlorambucil and the Type II CD20-Antibody GA101 In Patients with Chronic Lymphocytic Leukemia and Comorbidity: Results of the Run-In Phase of the CLL11 (BO21004) Trial

Valentin Goede, Kirsten Fischer, Busch Raymonde, Jaeger Ulrich, Marie-Sarah Dilhuydy, Nicholas Wickham, Sophie De Guibert, Anna Maria Fink, Susanne Hagist, Natali Pflug, Jasmin Bahlo, Gabriele Kranz, Gabriel Bieska, Kathryn Humphrey, Helen Bishop, Michael Wenger, Michael Hallek
Journal: Blood
Blood (2010) 116 (21): 1387.
https://doi.org/10.1182/blood.V116.21.1387.1387
Published: 2010
Journal Articles

Deregulation of miRNAs by Epigenetic Silencing Disrupts Suppression of the Oncogene PLAG1 in Chronic Lymphocytic Leukemia.

Christian P Pallasch, MD, Michaela Patz, PhD, Yoon Jung Park, PhD, Susanne Hagist, MD, Daniela Eggle, PhD, Rainer Claus, MD, Svenja Debey-Pascher, PhD, Alexandra Schulz, Lukas P Frenzel, MD, Julia Claasen, Nadine Kutsch, Günter Krause, PhD, Christine Mayr, MD, Andreas Rosenwald, MD, Christoph Plass, PhD, Joachim L Schultze, MD, Michael Hallek, MD, Clemens-Martin Wendtner, MD
Journal: Blood
Blood (2009) 114 (22): 3463.
https://doi.org/10.1182/blood.V114.22.3463.3463
Published: 2009
Journal Articles

miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia

Christian Philipp Pallasch, Michaela Patz, Yoon Jung Park, Susanne Hagist, Daniela Eggle, Rainer Claus, Svenja Debey-Pascher, Alexandra Schulz, Lukas P. Frenzel, Julia Claasen, Nadine Kutsch, Günter Krause, Christine Mayr, Andreas Rosenwald, Christoph Plass, Joachim L. Schultze, Michael Hallek, Clemens-Martin Wendtner
Journal: Blood
Blood (2009) 114 (15): 3255–3264.
https://doi.org/10.1182/blood-2009-06-229898
Published: 2009
Includes: Supplemental data
Journal Articles

Overexpression of TOSO in CLL Is Triggered by B-Cell Receptor Signaling and Associated with Progressive Disease.

Christian P Pallasch, MD, Alexandra Schulz, Nadine Kutsch, Janine Schwamb, Susanne Hagist, MD, Claudia Wickenhauser, MD, Alfred Ultsch, PhD, Hamid Kashkar, PhD, Michael Hallek, MD, Clemens-Martin Wendtner, MD
Journal: Blood
Blood (2008) 112 (11): 2070.
https://doi.org/10.1182/blood.V112.11.2070.2070
Published: 2008
Journal Articles

Deregulation of Micrornas Results in Overexpression of Oncogenic Transcription Factors Involved in Pathogenesis of CLL.

Christian P Pallasch, MD, Susanne Hagist, MD, Michaela Patz, Alexandra Schulz, Svenja Debey, Daniela Eggle, Joachim L Schultze, MD, Michael Hallek, MD, Clemens-Martin Wendtner, MD
Journal: Blood
Blood (2008) 112 (11): 2075.
https://doi.org/10.1182/blood.V112.11.2075.2075
Published: 2008
Journal Articles

Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease

Christian Philipp Pallasch, Alexandra Schulz, Nadine Kutsch, Janine Schwamb, Susanne Hagist, Hamid Kashkar, Alfred Ultsch, Claudia Wickenhauser, Michael Hallek, Clemens-Martin Wendtner
Journal: Blood
Blood (2008) 112 (10): 4213–4219.
https://doi.org/10.1182/blood-2008-05-157255
Published: 2008
Includes: Supplemental data
Journal Articles

The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgV H genes

Aditya Veldurthy, Michaela Patz, Susanne Hagist, Christian P. Pallasch, Clemens-Martin Wendtner, Michael Hallek, Günter Krause
Journal: Blood
Blood (2008) 112 (4): 1443–1452.
https://doi.org/10.1182/blood-2007-11-123984
Published: 2008
Includes: Supplemental data